Literature DB >> 26921446

Stroma-induced Jagged1 expression drives PC3 prostate cancer cell migration; disparate effects of RIP-generated proteolytic fragments on cell behaviour and Notch signaling.

Craig Delury1, Claire Hart2, Mick Brown3, Noel Clarke4, Edward Parkin5.   

Abstract

The Notch ligand Jagged1 is subject to regulated intramembrane proteolysis (RIP) which yields a soluble ectodomain (sJag) and a soluble Jagged1 intracellular domain (JICD). The full-length Jagged1 protein enhances prostate cancer (PCa) cell proliferation and is highly expressed in metastatic cells. However, little is known regarding the mechanisms by which Jagged1 or its RIP-generated fragments might promote PCa bone metastasis. In the current study we show that bone marrow stroma (BMS) induces Jagged1 expression in bone metastatic prostate cancer PC3 cells and that this enhanced expression is mechanistically linked to the promotion of cell migration. We also show that RIP-generated Jagged1 fragments exert disparate effects on PC3 cell behaviour and Notch signaling. In conclusion, the expression of both the full-length ligand and its RIP-generated fragments must be considered in tandem when attempting to regulate Jagged1 as a possible PCa therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Invasion; Jagged1; Metastasis; Migration; Notch signaling; Prostate cancer

Mesh:

Substances:

Year:  2016        PMID: 26921446     DOI: 10.1016/j.bbrc.2016.02.101

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.

Authors:  Clara H Lee; Ann M Decker; Frank C Cackowski; Russell S Taichman
Journal:  Cell Biol Toxicol       Date:  2019-06-27       Impact factor: 6.691

2.  LIM domain only 2 over-expression in prostate stromal cells facilitates prostate cancer progression through paracrine of Interleukin-11.

Authors:  Chen-Yi Jiang; Jun-Jie Yu; Yuan Ruan; Xiao-Hai Wang; Wei Zhao; Xing-Jie Wang; Yi-Ping Zhu; Yuan Gao; Kui-Yuan Hao; Lei Chen; Bang-Min Han; Shu-Jie Xia; Fu-Jun Zhao
Journal:  Oncotarget       Date:  2016-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.